Kenvue, Inc. (KVUE)

In the past six months, Kenvue's stock has been influenced by earnings reports, including Q4 2025 and Q1 2026 releases, the announcement of its acquisition by Kimberly-Clark expected to close in the second half of 2026, analyst ratings adjustments with a consensus "Hold" rating, and a restructuring initiative to reduce the workforce by approximately 3.5%.

Demand for Kenvue's products can be seasonal, particularly for allergy and sun care products, where an extended winter can negatively impact sales. The cough, cold, and flu franchises, as well as pediatric pain products, are also subject to seasonal incidences. Destocking by US retailers can cause shipments to trail consumption, affecting demand patterns.

Kenvue Inc. is an American consumer health company spun off from Johnson & Johnson in May 2023, becoming fully independent by August 2023. It is the world's largest pure-play consumer health company by revenue, with over $15 billion in annual sales. Kenvue operates in the Consumer Defensive sector, focusing on Self Care, Skin Health and Beauty, and Essential Health.

Kenvue has a significant global presence, serving consumers in over 165 countries with more than 20,000 employees and 25 in-house manufacturing facilities. Approximately half of its net sales in 2021 were generated outside North America. The company's products connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Kenvue's brand reputation is built on a heritage of over 135 years with iconic, science-backed brands. Kenvue released its second annual Healthy Lives Mission report, detailing a 37% reduction in operational emissions, expanded use of renewable electricity to 72%, and the launch of multiple packaging innovations. The company has consistently introduced over 100 new product innovations each year since 2020. However, the business faces pressure from store-brand competition and sluggish growth, particularly in the skincare business, and seasonal demand challenges.

Kenvue Inc. stock is primarily held by institutional shareholders, who own 94.74% of the company, while insiders own 10.97%, and retail investors hold 0.00%. Major institutional owners include Vanguard Group Inc. and BlackRock Inc. Johnson & Johnson is the largest individual shareholder, owning 9.50% of the company.